Revenue: The sum of all revenue fields included for a company's operating activities.
Novavax, Inc. (NVAX) had Revenue of $88.31M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$88.31M |
$-81.03M |
|
$36.67M |
|
$51.64M |
|
$219.39M |
|
$-131.08M |
|
$57.50M |
|
$-73.58M |
|
$-125.53M |
|
$-81.03M |
|
$-81.03M |
|
$-81.03M |
|
$-129.78M |
|
$-131.08M |
|
$-118.56M |
|
152.19M |
|
152.19M |
|
$-0.51 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$1.13B |
|
$138.41M |
|
$431.48M |
|
$1.56B |
|
$1.15B |
|
$223.41M |
|
$1.03B |
|
$2.18B |
|
$-623.84M |
|
$-731.32M |
|
$-623.84M |
|
160.42M |
|
| Cash Flow Statement Financials | |
$-87.26M |
|
$-204.04M |
|
$260.58M |
|
$583.81M |
|
$545.29M |
|
$-38.52M |
|
$48.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.98 |
|
-- |
|
-- |
|
-0.56 |
|
-0.37 |
|
58.48% |
|
-148.43% |
|
-148.43% |
|
-- |
|
-83.32% |
|
-91.76% |
|
$92.32M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
4.19 |
|
0.82 |
|
110.36 |
|
12.99% |
|
11.08% |
|
-5.19% |
|
20.24% |
|
$-3.89 |
|
$0.61 |
|
$-0.57 |
|